Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Mundle

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Leukemia|November 21, 1998
Apparent expansion of CD34+ cells during the evolution of myelodysplastic syndromes to acute myeloid leukemiaL F Span, S E Dar, V Shetty, et al.
Leukemia Research|January 28, 1998
The effects of 13-cis retinoic acid and interferon-alpha in chronic myelogenous leukemia cells in vivo in patientsH Handa, U P Hegde, V M Kotelnikov, et al.
American Journal of Hematology|January 12, 1999
Evidence for involvement of tumor necrosis factor-alpha in apoptotic death of bone marrow cells in myelodysplastic syndromesS D Mundle, A Ali, J D Cartlidge, et al.
British Journal of Haematology|June 10, 2000
Signal antonymy unique to myelodysplastic marrows correlates with altered expression of E2F1S D Mundle, B Y Mativi, J D Cartlidge, et al.
International Journal of Hematology|September 25, 1999
Spontaneous down-regulation of Fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrowsS D Mundle, B Y Mativi, K Bagai, et al.
ESMO Open|May 14, 2024
Perception of cure in prostate cancer: human-led and artificial intelligence-assisted landscape review and linguistic analysis of literature, social media and policy documentsE Efstathiou, A Merseburger, A Liew, et al.
Blood|October 1, 1996
Indication of an involvement of interleukin-1 beta converting enzyme-like protease in intramedullary apoptotic cell death in the bone marrow of patients with myelodysplastic syndromesS D Mundle, P Venugopal, J D Cartlidge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 2023
Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancerS Chowdhury, A Bjartell, N Agarwal, et al.
Experimental Hematology|June 1, 1997
Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo- and/or bromodeoxyuridineA Raza, S Alvi, L Broady-Robinson, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Leukemia|November 21, 1998
Apparent expansion of CD34+ cells during the evolution of myelodysplastic syndromes to acute myeloid leukemiaL F Span, S E Dar, V Shetty, et al.
Leukemia Research|January 28, 1998
The effects of 13-cis retinoic acid and interferon-alpha in chronic myelogenous leukemia cells in vivo in patientsH Handa, U P Hegde, V M Kotelnikov, et al.
American Journal of Hematology|January 12, 1999
Evidence for involvement of tumor necrosis factor-alpha in apoptotic death of bone marrow cells in myelodysplastic syndromesS D Mundle, A Ali, J D Cartlidge, et al.
British Journal of Haematology|June 10, 2000
Signal antonymy unique to myelodysplastic marrows correlates with altered expression of E2F1S D Mundle, B Y Mativi, J D Cartlidge, et al.
International Journal of Hematology|September 25, 1999
Spontaneous down-regulation of Fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrowsS D Mundle, B Y Mativi, K Bagai, et al.
ESMO Open|May 14, 2024
Perception of cure in prostate cancer: human-led and artificial intelligence-assisted landscape review and linguistic analysis of literature, social media and policy documentsE Efstathiou, A Merseburger, A Liew, et al.
Blood|October 1, 1996
Indication of an involvement of interleukin-1 beta converting enzyme-like protease in intramedullary apoptotic cell death in the bone marrow of patients with myelodysplastic syndromesS D Mundle, P Venugopal, J D Cartlidge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 2023
Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancerS Chowdhury, A Bjartell, N Agarwal, et al.
Experimental Hematology|June 1, 1997
Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo- and/or bromodeoxyuridineA Raza, S Alvi, L Broady-Robinson, et al.
Pageof 2